Mohammed Zarhrate

Mohammed Zarhrate

Auto-generated profile, based on publicly available information

Mohammed Zarhrate

Université Paris Cité 2 , Paris

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 December 2019 in Science Immunology
Verified
Journal Article
Open access
PDF file
CDChristopher J.A. Duncan
Christopher J.A. Duncan
BTBenjamin J. Thompson
Benjamin J. Thompson
RCRui Chen
Rui Chen
GRGillian I. Rice
Gillian I. Rice
FGFlorian Gothe
Florian Gothe
TBTracy A. Briggs
Tracy A. Briggs
STAT2 R148W impairs an essential regulatory function of STAT2, revealing the damage wreaked by excessive IFNα/β activity.

4 August 2022 in Journal of Medical Genetics
Verified
Journal Article
Closed access
PDF file
MAMarion Aubert-Mucca
Marion Aubert-Mucca
CHCéline Huber
Céline Huber
GBGenevieve Baujat
Genevieve Baujat
CMCaroline Michot
Caroline Michot
MZMohammed Zarhrate
Mohammed Zarhrate
VCValérie Cormier-Daire
Valérie Cormier-Daire
Background: Ellis-Van Creveld (EVC) syndrome is one of the entities belonging to the skeletal ciliopathies short rib–polydactyly subgroup. Major signs are ectodermal dysplasia, chondrodysplasia, polydactyly and congenital cardiopathy, with a high degree of variability in phenotypes ranging from lethal to mild clinical presentations. The EVC and EVC2 genes are the major genes causative of EVC syndrome. However, an increased number of genes involved in the ciliopathy complex have been identified in EVC syndrome, leading to a better understanding of its physiopathology, namely, WDR35, GLI1, DYNC2LI1, PRKACA, PRKACB and SMO. They all code for proteins located in the primary cilia, playing a key role in signal transduction of the Hedgehog pathways. Methods: The aim of this study was the analysis of 50 clinically identified EVC cases from 45 families to further define the phenotype and molecular bases of EVC. Results: Our detection rate in the cohort of 45 families was of 91.11%, with variants identified in EVC/EVC2 (77.8%), DYNC2H1 (6.7%), DYNC2LI1 (2.2%), SMO (2.2%) or PRKACB (2.2%). No distinctive feature was remarkable of a specific genotype–phenotype correlation. Interestingly, we identified a high proportion of heterozygous deletions in EVC/EVC2 of variable sizes (26.92%), mostly inherited from the mother, and probably resulting from recombinations involving Alu sequences. Conclusion: We confirmed that EVC and EVC2 are the major genes involved in the EVC phenotype and highlighted the high prevalence of previously unreported CNVs (Copy Number Variation).

8 March 2023 in JCI Insight
Verified
Journal Article
Open access
PDF file
PIPierre Isnard
Pierre Isnard
PVPaul Vergnaud
Paul Vergnaud
SGSerge Garbay
Serge Garbay
MJMatthieu Jamme
Matthieu Jamme
MEMaeva Eloudzeri
Maeva Eloudzeri
MRMarion Rabant
Marion Rabant
Acute kidney injury is one of the most important complications in patients with COVID-19 and is considered a negative prognostic factor with respect to patient survival. The occurrence of direct infection of the kidney by SARS-CoV-2, and its contribution to the renal deterioration process, remain controversial issues. By studying 32 renal biopsies from patients with COVID-19, we verified that the major pathological feature of COVID-19 is acute tubular injury (ATI). Using single-molecule fluorescence in situ hybridization, we showed that SARS-CoV-2 infected living renal cells and that infection, which paralleled renal angiotensin-converting enzyme 2 expression levels, was associated with increased death. Mechanistically, a transcriptomic analysis uncovered specific molecular signatures in SARS-CoV-2–infected kidneys as compared with healthy kidneys and non–COVID-19 ATI kidneys. On the other hand, we demonstrated that SARS-CoV-2 and hantavirus, 2 RNA viruses, activated different genetic networks despite triggering the same pathological lesions. Finally, we identified X-linked inhibitor of apoptosis-associated factor 1 as a critical target of SARS-CoV-2 infection. In conclusion, this study demonstrated that SARS-CoV-2 can directly infect living renal cells and identified specific druggable molecular targets that can potentially aid in the design of novel therapeutic strategies to preserve renal function in patients with COVID-19.

9 July 2026 in Journal of Experimental Medicine
Verified
Journal Article
Closed access
FAFlorence Assan
Florence Assan
MTMargot Tragin
Margot Tragin
SMSahiti Marella
Sahiti Marella
JLJoanna Lipecka
Joanna Lipecka
KRKevin Roger
Kevin Roger
HBHervé Bachelez
Hervé Bachelez
Recent evidence implicates altered RNA editing and dysregulated type I IFN signaling in immune-mediated diseases, including psoriasis, although the underlying genetic mechanisms remain poorly defined. We investigated four unrelated multiplex families with early-onset plaque psoriasis, with or without psoriatic arthritis, segregating as a monogenic trait and characterized by a strong IFN signature in skin and blood. Whole-exome sequencing identified four rare heterozygous loss-of-function mutations in ADAR1 cosegregating with disease and elevated IFN-stimulated gene expression. Six additional rare variants were detected in an independent cohort of 125 psoriasis patients. Single-cell transcriptomics identified keratinocytes and melanocytes as major IFN sources. Functional studies showed that ADAR1 knockdown or expression of ADAR1G1119R and ADAR1P3A alleles pathogenic variants reduced adenosine-to-inosine RNA editing and increased IFN-stimulated genes and inflammatory cytokines, effects reversed by upadacitinib and deucravacitinib. These findings define a novel IFN-dependent psoriasis subtype caused by inborn defects of ADAR1-mediated RNA editing, with direct implications for precision medicine in psoriatic disease.

6 May 2026 in Journal of Human Immunity
Verified
Journal Article
Open access
NMNidia Carolina Moreno-Corona
Nidia Carolina Moreno-Corona
AVAlice Valagussa
Alice Valagussa
LPLucie Poggi
Lucie Poggi
OLOrestes López-Ortega
Orestes López-Ortega
CMCécile Masson
Cécile Masson
SKSven Kracker
Sven Kracker
Ribosomopathies are rare genetic disorders associated with abnormalities in the production and function of ribosomes. We describe here our study of a patient presenting with hypogammaglobulinemia and autism spectrum disorder. Genetic analyses revealed compound-heterozygous variants in the WDR75 gene. WDR75 encodes a component of the SSU processome, a large ribonucleoprotein complex involved in the early stages of small ribosomal subunit assembly. Functional studies in cells derived from the patient and a cell line modified by CRISPR/Cas9 showed altered processing of pre-rRNA (A0 cleavage) and increased expression of p21, suggesting a predisposition to nucleolar stress and partial activation of the p53 pathway. While these observations do not prove causality between genotype and phenotype, they suggest a possible association between WDR75 genetic variants and nuclear stress, which may contribute to the clinical presentation.

22 June 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
STShengjiang Tan
Shengjiang Tan
LKLaëtitia Kermasson
Laëtitia Kermasson
CHChristine Hilcenko
Christine Hilcenko
VKVasileios Kargas
Vasileios Kargas
DTDavid Traynor
David Traynor
PRPatrick Revy
Patrick Revy